To examine the prevalence of disease burden and disability associated with overweight and obesity in men aged 60-79 y and to assess whether the current WHO weight guidelines are appropriate in the elderly. DESIGN: Cross-sectional survey 20 y after enrolment. SETTING: General practices in 24 British towns. PARTICIPANTS: In total, 4232 men aged 60-79 y (77% of survivors) with measured weight and height. MAIN OUTCOME MEASURES: Cardiovascular (CV) risk factors, prevalence of diabetes, cardiovascular disease, cancer, disability and regular medication. RESULTS: In total, 17% of the men were obese (body mass index (BMI) Z30 kg/m 2 ) and a further 52% were overweight (BMI 25-29.9 kg/m 2 ). Prevalence of hypertension, low HDL-cholesterol, high triglycerides and insulin resistance and the prevalence of most disease outcomes increased with increasing degrees of overweight/obesity. Men in the normal weight range (18.5-24.9 kg/m 2 ) had the lowest prevalence of ill health. Compared with normal weight men, obese men showed a two-fold risk of major CVD (odds ratio (OR) ¼ 1.96, 95% CI 1.44-2.67) and locomotor disability (OR ¼ 2.26, 95% CI 1.66, 3.09) and were nearly three times as likely to have diabetes, CV interventions or to be on CV medication. Over 60% of the prevalence of high insulin resistance was attributable to overweight and obesity as was over a third of diabetes and hypertension, a quarter of locomotor disability and a fifth of major CVD. CONCLUSION: In elderly men, overweight and obesity are associated with a significantly increased burden of disease, in particular CV-related disorders and disability. The current guidelines for overweight and obesity appear to be appropriate in elderly men.
Introduction
During the past few decades, the prevalence of obesity (BMIZ30 kg/m 2 ) has reached epidemic levels in Western societies. 1, 2 In the UK, 17% of men and 21% of women are obese. 2 Overweight and obesity constitute a major public health problem because of the associated increased risk of coronary heart disease (CHD), stroke, type 2 diabetes, hypertension, dyslipidemia, musculoskeletal disorders and some cancers. 1, 2 Mean body weight increases with age; in most studies the increase continues up to about age 60 and then levels off. 3 Both the National Heart, Lung and Blood
Institute (NHLBI) of the National Institutes of Health (NIH) 4 and WHO 5 now recommend 25 kg/m 2 as the upper limit of ideal weight for all adults regardless of age. However, the importance of overweight and obesity as predictors of mortality in elderly people (465 y) has been controversial, with several studies failing to show any relation between overweight/obesity and mortality. 6 A recent review has suggested that the weight guidelines may be 'overly restrictive' as they apply to all cause and cardiovascular mortality in elderly people. 6 The impact of obesity on morbidity and disability has shown to be higher than the impact on mortality. 7 Reports estimating prevalence of disease burden associated with overweight and obesity using the current guidelines have generally been carried out in middle-aged populations or in populations with a broad age range. 8, 9 We have examined the prevalence of a wide range of outcomes and indicators of ill health related to overweight and obesity, based on the current guidelines and with particular focus on cardiovascular-related disorders and on disability in a large population-based study of men aged 60-79 y.
Subjects and methods
The British Regional Heart Study is a prospective study of cardiovascular disease involving 7735 men aged 40-59 y selected from the age-sex registers of one general practice in each of 24 British towns, who had their initial examination between 1978 and 1980. 10 Research nurses administered a standard questionnaire including questions on lifestyle factors and medical history. All men have been followed up for all cause mortality, cardiovascular morbidity and development of type 2 diabetes from the initial screening. 11 In 1998-2000, all surviving men, now aged 60-79 y, were invited for a 20th year re-examination, carried out in a local health center. All men completed a mailed questionnaire (Q20) providing information on their medical history and lifestyle factors, had a physical examination and provided a fasting blood sample. The men were asked to fast for a minimum of 6 h and to attend for measurement at a prespecified time between 0800 and 2000. Of the 5565 surviving subjects, 4252 (77%) attended for examination.
Cardiovascular risk factors
Details of classification methods and measurements of the cardiovascular risk factors (including social class, physical activity, alcohol intake, smoking) have been described. [10] [11] [12] [13] Systolic blood pressure at Q20 (Dinamap reading) was adjusted by subtracting 8 mmHg from the reading to accord with the Hawksley random zero sphygmanometer readings at baseline. 14 Blood pressure was adjusted for observer variation. 15 Hypertension is defined as systolic blood pressure Z160 mmHg or diastolic blood pressure Z90 mmHg or on antihypertensive treatment. 16 Serum triglycerides, insulin and glucose were adjusted for the effects of fasting duration and time of day. 13 High cholesterol was defined as levels Z240 mg/dl (Z6.2 mmol/l), low HDL-C as levels o40 mg/dl (o1.0 mmol/l), and high triglycerides as levels Z200 mg/dl (Z2.3 mmol/l). 17 Insulin resistance was estimated according to the homeostasis model assessment (HOMA) as the product of fasting glucose (mmol/l) and insulin (mU/ml) divided by the constant 22.5. 18 HOMA scores were not calculated for diabetic men and for those with a fasting glucose of Z7 mmol/l, as the index is not valid in this group.
18
Body mass index and weight change At initial examination (1978) (1979) (1980) excluded from the data analysis in Tables 1-5 . The percentage change in body weight since initial examination was calculated for each man 19 and a loss or gain of 4% defined a 'change in weight'. 19 The men were also asked whether they had lost weight in the 3 y prior to re-examination in 1998-2000.
Indicators of ill-health at re-examination
Self perception of healthFThe men were asked to describe their present health status as excellent, good, fair or poor. Overweight and obesity and the burden of disease and disability S Goya Wannamethee et al
Recall of doctor diagnosisFThe men were asked whether a doctor had ever told them that they had angina or myocardial infarction (heart attack, coronary thrombosis), stroke, 'other heart trouble', deep vein thrombosis (DVT), intermittent claudication (IC), pulmonary embolism (PE), high blood pressure, diabetes or cancer. Prevalence of cardiovascular outcomes (myocardial infarction, angina, stroke) were based on regular biennial review of general practice (GP) medical records (including hospital and clinic correspondence) and on recall of doctor diagnoses obtained by questionnaires.
DiabetesFMen with a diagnosis of diabetes (GP reporting or recall) and those with a fasting glucose of Z7 mmol/l were considered to have prevalent diabetes.
MedicationFThe men were asked about regular treatment and were required to bring their medication to the examination session. The medications were coded according to the British National Formulary (BNF) codes. 20 Cardiovascular medicine included drugs used in the treatment of diseases of the cardiovascular system (BNF 2.1-2.13). Respiratory medicine included BNF codes 3.1-3.10 and musculoskeletal and joint diseases included all drugs used in the treatment of rheumatic diseases, neuromuscular disorder and soft tissue inflammation (BNF 10.1-10.3). Cardiovascular interventionFThis included men who had ever had angioplasty or coronary artery bypass operation for chest pain or heart disease.
DisabilityFThey were asked if they had any long-standing illness, disability or infirmity resulting in current difficulty with carrying out any of the following activities on their own: (i) going up or down stairs, (ii) bending down/ straightening up, (iii) falling or difficulty keeping balance, or (iv) walking for a quarter of a mile on the level. Men who responded positively to any of these questions were described as having locomotor disability.
Activities of daily livingFThey were asked if they had problems performing usual activities (eg work, housework, family activities) and self-care (washing and dressing).
Statistical analysis
Multiple logistic regression was used to estimate the odds ratio (relative odds) and 95% confidence intervals (CI) with adjustment for potential confounding factors. In these [3] HOMA ¼ homeostasis model for assessment of insulin resistance; [4] FEV 1 ¼ forced expiratory volume in 1 s.
Overweight and obesity and the burden of disease and disability S Goya Wannamethee et al models age was entered as a continuous variable, social class (based on longest held occupation) (I, II, III nonmanual vs III manual, IV, V and Armed Forces), physical activity (five levels), alcohol intake (five levels) and smoking (never, long term ex-cigarette smoker, recent ex-cigarette smoker (gave up in 1996) and current cigarette smokers) were entered as categorical variables. Tests for linear trend were carried out fitting BMI as a continuous variable. To test for nonlinear trends a quadratic term was fitted to a model that included a linear term. We have assessed the proportion of the total population who have CV-related disorders and disability attributed to overweight or obesity (ie what proportion of men would not have the disease in the absence of overweight and obesity) by calculating population attributable risk fractions (PARF). Odds ratios (ORs) for each BMI category using normal weight (18.5-24.9 kg/m 2 ) as the reference group were used to calculate PARF using the equation:
where P i is the prevalence of the overweight and obesity category i and OR i the odds ratio associated with the specific overweight and obesity category i.
The PARF values for the overweight and obese categories were added together to estimate the overall population attributable risk fraction associated with overweight and obesity.
Results
The mean BMI in the 4232 men with available data on BMI rose from 25 of the men (initially 7%) and a further 52% were overweight (initially 47%). Men in the normal weight range were more likely to have been stable in weight. The majority of men who were overweight or obese had gained weight since initial examination. BMI was inversely related to age and current smoking and positively associated with heavier drinking. Both obese and underweight men were more likely to be manual workers and physically inactive than men in the normal weight range. Table 2 shows the unadjusted prevalence rates and the odds ratios of having high/low levels of the biological cardiovascular risk factors, adjusting for age, smoking, physical activity, social class and alcohol intake. Prevalence and Overweight and obesity and the burden of disease and disability S Goya Wannamethee et al adjusted odds ratio of systolic and diastolic hypertension, low HDL-cholesterol, high triglycerides and high HOMA (measure of insulin resistance) increased significantly and sharply at higher levels of BMI. No significant association was seen with raised blood cholesterol. A U-shaped relationship was seen with lung function with normal weight men showing higher odds ratio of low lung function than men who were overweight (quadratic trend P ¼ 0.03).
BMI and cardiovascular risk factors
Indicators of morbidity Table 3 shows the unadjusted prevalence rates of indicators of ill health. The normal weight group had the highest prevalence of excellent health, with obese men having the highest prevalence of poor/fair health. Prevalence rates of doctor diagnosed heart attack, angina and stroke were only increased in obese men. However, prevalence of diabetes, DVT, high blood pressure, locomotor disability, and the use of medication for treating cardiovascular diseases, hypertension and musculoskeletal/joint diseases increased significantly at higher levels of BMI. Normal weight men had higher rates of cancer and use of medication for respiratory diseases than overweight men (25-29.9 kg/m 2 ) and rates were similar to obese men. Table 4 shows the adjusted odds ratios for the indicators of ill-health using men in the normal weight range as the reference group. Obese men had by far the highest odds ratios for all indicators except cancers and respiratory disease. Overweight men, even at the lower range of overweight (25-27.4 kg/m 2 ), tended to have higher odds of CV-related ill health, locomotor disability and musculoskeletal problems than men in the normal weight range. With the exception of diagnosis of high blood pressure and medication for CVD, high blood pressure and musculoskeletal and joints there was no evidence of a significant curvilinear relation or U-shaped relation with these outcome measures after adjustment. The significant quadratic trends seen for these factors represented a curvilinear relationship with risk increasing up to levels of 30 kg/m 2 and levelling off thereafter. Exclusion of men with recent weight loss (in the 3 y prior to re-examination) made minor differences to the relationships seen with cancer and medication for respiratory disease but normal weight men now had the lowest odds of poor/fair health (adjusted OR 1.00, 1.07 (0.84-1.37), 1.37 (1.03,1.82) and 2.23 (1.57,3.11) for the four groups respectively). The positive relationships with cardiovascular diseases, for example heart attacks and angina, strengthened after 
Nonsmokers
Since some studies have indicated a stronger relationship between higher BMI and mortality in never smokers, 22 we also examined the relationship between BMI and CV risk factors and main health outcome measures in 1224 men who had never smoked. The positive relationships seen between overweight and obesity and CVD-related outcome and disability were even stronger in men who had never smoked (Table 5) . There were only 689 men aged 75 y or above at reexamination but the adverse effect of overweight and obesity on CVD-related health outcome, use of medication and disability were also seen in these men (data not shown).
Population attributable risk fractions
The population attributable risks fractions for cardiovascular disease, interventional treatment and disability attributable to overweight and obesity are shown in the Figure 1 . High insulin resistance and low HDL-cholesterol were most strongly attributed to overweight and obesity (64 and 48% respectively). Over a third of cardiovascular intervention (40%), use of antihypertensive treatment (40%), diabetes (38%), a third of hypertension (33%) and cardiovascular medication use (31%), a quarter of locomotor disability (26%) and a fifth of major CVD (19%) in the population were attributable to overweight and obesity.
Discussion
In this cohort of British men aged 60-79 y, over two-thirds of the men were either overweight (52%) or obese (17%), very similar to the prevalence rates reported in the 1998 Health Survey for England (46% overweight and 17% obese). 23 The influence of age on the relationship of BMI to morbidity and mortality has been a subject of much debate. Many studies have failed to find any significant association between BMI and all-cause mortality in the elderly (Z65 y) and some studies based on mortality outcome have even suggested a protective effect of overweight (25-29.9 kg/m 2 ) in older subjects. 3, 6 It has been suggested that the cutoff point of Z25 kg/m 2 for overweight might overestimate the risks for older people 6 and that this threshold should be raised, as BMI levels between 25.0 and 29.0 kg/m 2 may not be associated with excess risk in the elderly. 24 We have observed in this cross-sectional study that the prevalence of CV risk factors and morbidity (particularly cardiovascular-related diseases), disability and medication use, increased significantly with increasing degree of overweight and obesity in this age-group. The effects were even stronger in never Overweight and obesity and the burden of disease and disability S Goya Wannamethee et al smokers, which is consistent with studies showing stronger positive relations between BMI and mortality in never smokers. 22 Overweight, obesity and CV risk factors BMI showed strong graded associations with many CV risk factors including hypertension, low HDL-cholesterol, high triglycerides (but not high blood cholesterol) and high insulin resistance, with risk increasing sharply with increasing overweight and obesity. It is evident that cardiovascular risk factors continue to be highly associated with BMI even in the elderly, as has been observed in other studies. 25, 26 It is estimated that over 60% of raised insulin resistance in this population, 48% of low HDL-cholesterol and about a third of hypertension (33%) is attributable to overweight/obesity.
Morbidity and disability
Overweight and obesity is associated with several disease outcomes leading to long-term medication, in particular CVrelated diseases and disability, which is reflected in the increased prevalence of antihypertensive treatment, cardiovascular medication and cardiovascular intervention in overweight and obese men compared to men of normal weight. Although we did not have information on prevalence of noncardiovascular diseases other than cancers, medication for musculoskeletal and joint diseases was more prevalent in the overweight and obese reflecting the known association between obesity and arthritis. Reporting of locomotor disability and difficulty with activities of daily living increased progressively with increasing degrees of overweight and obesity. Men in the upper range of the overweight category (27.5-29.9 kg/m 2 ) were 50% more likely to report locomotor disability than normal weight men and in obese men the odds were over two-fold. This is consistent with other reports that have reported a two-fold increase in risk of mobility-related disability for men in the top quintile of body weight 25 or fat mass 27 Although the prevalence data from the present study are based on 77% of survivors, the mean BMI of those who attended re-examination and nonattenders were almost identical, although disabled people were less likely to attend. 28 While the prevalence of disability may be underestimated, this is unlikely to affect the BMI-disability relationships.
Recent weight loss
It has been shown that in older people, heavier weight (BMI Z27 kg/m 2 ) is associated with increased risk only when those with recent substantial weight loss were excluded. 29 The positive association between overweight and obesity and cardiovascular disease in our study was strengthened after exclusion of men who had lost weight in the 3 y prior to reexamination. The impact of body weight on health status in the elderly is thus likely to be underestimated if weight history is not taken into account. Despite these limitations, it was estimated from the present cross-sectional study that nearly 40% of the burden of diabetes, a third of medication use for cardiovascular-related diseases in the elderly, a quarter of locomotor disability and a fifth of major CVD was attributable to overweight and obesity.
Age, overweight, obesity and disease burden Studies on the burden of disease associated with overweight or obesity using the current WHO and NIH guidelines have generally been carried out in younger populations or have focused on limited end points. 8, 9 In an US cross-sectional study, the relationship between overweight and obesity and the comorbidities studied (diabetes, gall bladder disease, CHD, blood cholesterol and blood pressure) was generally stronger among the younger age group (o55 y) than the older age-group (Z55 y), based on prevalence ratios. 9 However, given the higher incidence rates of morbidity in the elderly, particularly for diabetes and hypertension, the absolute excess risk of disease associated with overweight and obesity is likely to be substantial. Thus, while overweight (25.0-29.9 kg/m 2 ) may not be associated with increased mortality in the elderly, it contributes considerably to increased morbidity and disability resulting in diminished quality of life.
Other measures of adiposity It is well recognized that an indirect measure of anthropometry such as BMI is an inaccurate measure of body fatness in the elderly because of the decrease in skeletal muscle mass and increase in abdominal fat with aging. 30 Several studies have reported other measures of body fat such as centrality index (abdominal/femoral fat) and waist circumference to be better correlated with blood pressure, lipid profile and atherogenic index than the BMI in the elderly. 31, 32 In many studies waist circumference (WC) or waist-to-hip ratio (WHR) have been shown to be better predictors of mortality than BMI in older men [33] [34] [35] and WC has been shown to help identify those at increased risk within the normal weight, overweight and obese BMI categories. 36 These findings suggest that WC may be a better indicator of overall body fat and health risk in older subjects than the BMI and it has been suggested that the BMI and WHR should be used in conjunction to characterize subjects at high risk. However, some studies have shown the combination of WC and BMI to make only a minor improvement in prediction of CV risk factors over either the BMI or WC alone. 37 Despite its limitations we have shown strong positive relationships between BMI and CV risk factors and have shown overweight and obesity using BMI cutoff points to be associated with increased prevalence of morbidity in the elderly. The main focus of this paper has been to assess whether the WHO guidelines for overweight and obesity using the current BMI definitions are appropriate
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Conclusion
In this study, overweight even of moderate degree and obesity are both associated with a substantial increase in the burden of CV-related disorders, overall medication and disability and it appears that the guidelines recommended by WHO and the NIH (NHLBI) for overweight and obesity apply to these elderly men. With an increasing life expectancy, an increase in the population prevalence of overweight and obesity will lead to an increase in the population burden of ill health in the future due to increased nonfatal morbidity and disability.
